CLINICAL_TRIALS trial_result · 2014-10-23

Clinical Trial Update: Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma [Phase 2]

A Phase II cancer vaccine trial for Follicular Lymphoma has completed enrollment with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Oslo University Hospital | Conditions: Follicular Lymphoma | Phase 2 | Status: COMPLETED